Cargando…
Marine-Derived Pharmaceuticals – Challenges and Opportunities
Marine biosphere is the largest one of the earth and harbors an enormous number of different organisms. Living conditions differ fundamentally from those in terrestrial environment. The production of specific secondary metabolites is an important adaption mechanism of marine organisms to survive in...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098534/ https://www.ncbi.nlm.nih.gov/pubmed/27795450 http://dx.doi.org/10.4062/biomolther.2016.181 |
_version_ | 1782465798856507392 |
---|---|
author | Lindequist, Ulrike |
author_facet | Lindequist, Ulrike |
author_sort | Lindequist, Ulrike |
collection | PubMed |
description | Marine biosphere is the largest one of the earth and harbors an enormous number of different organisms. Living conditions differ fundamentally from those in terrestrial environment. The production of specific secondary metabolites is an important adaption mechanism of marine organisms to survive in the sea. These metabolites possess biological activities which make them interesting as possible drugs for human. The review presents sources, chemistry, production and pharmacology of FDA approved marine derived pharmaceuticals arranged according to their therapeutic indication. Four of the presently seven approved drugs are used for the treatment of cancer. Each another one is applicated for treatment of viral diseases, chronic pain and to lower triglyceride level in blood. Some other products are of interest in diagnostic and as experimental tools. Besides, this article describes challenges in drug development from marine sources, especially the supply problem. |
format | Online Article Text |
id | pubmed-5098534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | The Korean Society of Applied Pharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-50985342016-11-14 Marine-Derived Pharmaceuticals – Challenges and Opportunities Lindequist, Ulrike Biomol Ther (Seoul) Invited Review Marine biosphere is the largest one of the earth and harbors an enormous number of different organisms. Living conditions differ fundamentally from those in terrestrial environment. The production of specific secondary metabolites is an important adaption mechanism of marine organisms to survive in the sea. These metabolites possess biological activities which make them interesting as possible drugs for human. The review presents sources, chemistry, production and pharmacology of FDA approved marine derived pharmaceuticals arranged according to their therapeutic indication. Four of the presently seven approved drugs are used for the treatment of cancer. Each another one is applicated for treatment of viral diseases, chronic pain and to lower triglyceride level in blood. Some other products are of interest in diagnostic and as experimental tools. Besides, this article describes challenges in drug development from marine sources, especially the supply problem. The Korean Society of Applied Pharmacology 2016-11 2016-11-01 /pmc/articles/PMC5098534/ /pubmed/27795450 http://dx.doi.org/10.4062/biomolther.2016.181 Text en Copyright ©2016, The Korean Society of Applied Pharmacology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Invited Review Lindequist, Ulrike Marine-Derived Pharmaceuticals – Challenges and Opportunities |
title | Marine-Derived Pharmaceuticals – Challenges and Opportunities |
title_full | Marine-Derived Pharmaceuticals – Challenges and Opportunities |
title_fullStr | Marine-Derived Pharmaceuticals – Challenges and Opportunities |
title_full_unstemmed | Marine-Derived Pharmaceuticals – Challenges and Opportunities |
title_short | Marine-Derived Pharmaceuticals – Challenges and Opportunities |
title_sort | marine-derived pharmaceuticals – challenges and opportunities |
topic | Invited Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098534/ https://www.ncbi.nlm.nih.gov/pubmed/27795450 http://dx.doi.org/10.4062/biomolther.2016.181 |
work_keys_str_mv | AT lindequistulrike marinederivedpharmaceuticalschallengesandopportunities |